Skip to content

D&A at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$3.22M-7.9%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
$714K-11.1%
USANA Health Sciences logo
USANA Health SciencesUSNA
$8.28M-0.7%
Estee Lauder Companies Inc. logo
Estee Lauder Companies Inc.EL
$201M-1.5%
Herbalife logo
HerbalifeHLF
$29.4M-4.2%
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
$313K+38.5%

Segments

By segment

See full
Rhyz$3.59M-15.4%
Manufacturing$3.25M-2.5%
Mainland China$1.79M-13.7%
Rhyz Other$340K-62.7%
Hong Kong Taiwan$250K-33.7%
Europe And Africa$171K-35.2%

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-34.9%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's D&A?
NuSkin Enterprises (NUS) reported D&A of $12.34M in Q1 2026.
How has NuSkin Enterprises's D&A changed year-over-year?
NuSkin Enterprises's D&A decreased by 13.1% year-over-year, from $14.21M to $12.34M.
What is the long-term trend for NuSkin Enterprises's D&A?
Over 4 years (2021 to 2025), NuSkin Enterprises's D&A has grown at a -9.0% compound annual growth rate (CAGR), from $76.32M to $52.26M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.